GSK’s CEO Walmsley aiming for six new approvals in 2020

GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes to get at least six new drug approvals in the next year.

In an interview at the JP Morgan Healthcare Conference in San Francisco with CNBC, Walmsley said there is a lot of data expected in 2020.